-
CYTOMEGALOVIRUS INFECTION IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS RECEIVING CYTOMEGALOVIRUS PROPHYLAXIS: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
ASSESSING THE SIX HTA CORE PILLARS AS A RELIABLE AND INTEGRATED FRAMEWORK FOR TIMELY AND EQUITABLE ACCESS IN THE MENA REGION
Aug 11, 2026, 17:16 PM -
OPTIMIZING THE INTEGRATION OF AI IN A COMPLEX SYSTEMATIC LITERATURE REVIEW: VALIDATION ACROSS TITLE/ABSTRACT AND FULL-TEXT STAGES
Aug 11, 2026, 17:16 PM -
EQUITY BY DESIGN: A NATIONWIDE GEOSPATIAL ASSESSMENT OF BRAZIL'S CAPACITY TO DELIVER INTRAVENOUS ALS THERAPIES
Aug 11, 2026, 17:16 PM -
ACCURACY AND CLINICAL SAFETY OF FREESTYLE LIBRE 2 CONTINUOUS GLUCOSE MONITORING IN HOSPITALIZED AND CRITICALLY ILL PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Aug 11, 2026, 17:16 PM -
COST UTILITY OF INTRAVENTRICULAR TIGECYCLINE VERSUS INTRAVENTRICULAR COLISTIMETHATE SODIUM IN EXTENSIVELY DRUG-RESISTANT CENTRAL NERVOUS SYSTEM INFECTIONS: A RETROSPECTIVE MULTI-CENTRE ANALYSIS
Aug 11, 2026, 17:16 PM -
MAKING SYNTHETIC DATA ACTIONABLE FOR HTA: A PRELIMINARY FRAMEWORK FOR CLINICAL AND HTA EVALUATIONS - APPLICATIONS, REQUIREMENTS, AND CONDITIONS OF USE FROM THE ITALIAN EXPERIENCE
Aug 11, 2026, 17:16 PM -
ASSESSING THE IMPACT OF US MFN POLICY ON EMA APPROVAL TIMING FOLLOWING FDA APPROVAL: AN EXPLORATORY ANALYSIS
Aug 11, 2026, 17:16 PM -
HOSPITAL COSTS OF TREATING INFANTILE-ONSET SMA PATIENTS WITH HIGH DOSE NUSINERSEN (50/28 MG) VS STANDARD DOSE NUSINERSEN (12/12 MG) IN ITALY
Aug 11, 2026, 17:16 PM -
UNCOVERING THE HIDDEN COSTS OF AUTOMATIC BIOSIMILAR SUBSTITUTION THROUGH BESPOKE ECONOMIC MODELING APPROACH
Aug 11, 2026, 17:16 PM -
ASSOCIATIONS BETWEEN BRONCHIECTASIS SYMPTOMS AND CLINICAL OUTCOMES: PROTOCOL FOR A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS FEASIBILITY ASSESSMENT
Aug 11, 2026, 17:16 PM -
SUPPORTING DECISION-GRADE CLINICAL BENCHMARKING FOR PERCUTANEOUS CORONARY INTERVENTION: RE-DEVELOPMENT AND TEMPORAL VALIDATION OF A NATIONAL RISK MODEL FOR POST-PCI MORTALITY
Aug 11, 2026, 17:16 PM -
EARLY ECONOMIC EVALUATION OF BLOOD-BRAIN BARRIER MODULATION ACROSS LUNG CANCER BRAIN METASTASIS TREATMENT PATHWAYS IN THE UK NHS
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF RISANKIZUMAB VERSUS USTEKINUMAB FOR THE TREATMENT OF BIOLOGIC-FAILED CROHN'S DISEASE IN CHINA
Aug 11, 2026, 17:16 PM -
THE EFFECT OF EDUCATIONAL CAMPAIGNS AND PUBLIC FIGURES' CANCER DIAGNOSES ON PANCREATIC CANCER-RELATED ONLINE INFORMATION-SEEKING BEHAVIOR: A HUNGARIAN EXPERIENCE
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT OF ACTISTM HIP SYSTEM AND KINCISETM 2 SYSTEM IN PATIENTS UNDERGOING PRIMARY TOTAL HIP ARTHROPLASTY IN SPAIN...
Aug 11, 2026, 17:16 PM -
CHANGES IN PHYSICAL AND COGNITIVE STATUS FOLLOWING HOSPITALIZATION FOR RESPIRATORY TRACT INFECTIONS IN OLDER ADULTS: A POPULATION-BASED STUDY USING JAPANESE ADMINISTRATIVE DATA
Aug 11, 2026, 17:16 PM -
VIGNETTE-DERIVED HEALTH STATE UTILITIES IN SCANDINAVIAN HTA ASSESSMENTS
Aug 11, 2026, 17:16 PM -
FIT FOR PREVENTION? VACCINES UNDER THE EUROPEAN UNION JOINT CLINICAL ASSESSMENT FRAMEWORK: A TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
EVIDENCE FOR RENAL RECOVERY WITH AVACOPAN IN ANCA-ASSOCIATED VASCULITIS AND POTENTIAL IMPLICATIONS FOR HEALTHCARE RESOURCE UTILIZATION
Aug 11, 2026, 17:16 PM
